https://www.marketscreener.com/quote/stock/BIOSIG-TECHNOLOGIES-INC-46321442/news/ViralClear-Expands-Ongoing-Phase-2-Trial-Size-for-its-Oral-Anti-Viral-for-the-Treatment-of-COVID-19-31339771/?utm_source=telegram&utm_medium=social&utm_campaign=share